• Fifty-one patients with psoriasis were treated with oral methoxsalen and sunlight exposure. Twelve of these patients received either methoxsalen or placebo prior to whole-body exposure. The remainder were treated with methoxsalen and sunlight to one side of the body and sunlight alone to the other. The conventional dose of methoxsalen (0.6 mg/kg) was compared with a low dose (0.3 mg/ kg). Oral methoxsalen when used in the higher dose followed by sun exposure is an effective treatment for psoriasis. Accurate ultraviolet dosimetry is essential to avoid phototoxic burns. The advantages and disadvantages of solar photochemotherpy are discussed.
(Arch Dermatol 113:1529-1532, 1977)
Parrish JA, White HAD, Kingsbury T, Zahar M, Fitzpatrick TB. Photochemotherapy of Psoriasis Using Methoxsalen and Sunlight: A Controlled Study. Arch Dermatol. 1977;113(11):1529–1532. doi:10.1001/archderm.1977.01640110049006
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: